More about

Eye Drop

News
April 17, 2024
2 min read
Save

First patient enrolled LYNX-2 study of eye drop for reduced visual acuity in low light

First patient enrolled LYNX-2 study of eye drop for reduced visual acuity in low light

Ocuphire Pharma has enrolled the first patient in its LYNX-2 phase 3 registration study of phentolamine ophthalmic solution 0.75% for treatment of reduced visual acuity under low-light conditions after keratorefractive surgery.

News
April 16, 2024
2 min watch
Save

VIDEO: Lindstrom highlights two dry eye treatments from Surface Ophthalmics

VIDEO: Lindstrom highlights two dry eye treatments from Surface Ophthalmics

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Richard L. Lindstrom, MD, overviews two dry eye products from Surface Ophthalmics.

News
April 01, 2024
1 min read
Save

Viatris launches Ryzumvi for mydriasis reversal

Viatris launches Ryzumvi for mydriasis reversal

Viatris is launching the first commercially available, FDA-approved eyedrop for the reversal of dilation, according to a press release.

News
March 28, 2024
1 min watch
Save

VIDEO: Miebo stops evaporation, keeps tears flowing

VIDEO: Miebo stops evaporation, keeps tears flowing

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Douglas Katsev, MD, and Julia Katsev Larson, OD, discuss the use of Miebo for dry eye disease.

News
March 15, 2024
1 min read
Save

Diabetic retinopathy eye drop trial fails to meet primary efficacy endpoint

Diabetic retinopathy eye drop trial fails to meet primary efficacy endpoint

OcuTerra Therapeutics is evaluating strategic alternatives after the phase 2 DR:EAM trial failed to meet its primary efficacy endpoint, according to a press release.

News
March 12, 2024
1 min read
Save

Small-molecule eye drop safe, well-tolerated as treatment for retinal vascular diseases

Small-molecule eye drop safe, well-tolerated as treatment for retinal vascular diseases

Exonate has announced successful safety and tolerability data from its phase 1b/2a trial of EXN407, a topical small-molecule therapeutic for retinal vascular diseases, such as diabetic retinopathy and diabetic macular edema.

News
March 05, 2024
1 min read
Save

Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain

Clobetasol propionate ophthalmic suspension 0.05% approved for postop inflammation, pain

The FDA approved clobetasol propionate ophthalmic suspension 0.05% for the treatment of inflammation and pain after ocular surgery, according to a press release from Formosa Pharmaceuticals and AimMax Therapeutics.

News
February 02, 2024
1 min read
Save

FDA warns against use of possibly contaminated copycat eye drops

FDA warns against use of possibly contaminated copycat eye drops

The FDA has issued a warning to consumers not to purchase or use South Moon, Rebright or FivFivGo eye drops because of possible contamination and risk for eye infection.

News
January 23, 2024
2 min read
Save

BLOG: The secret is out about Lacrifill

BLOG: The secret is out about Lacrifill

You know when you’ve got really good news about something super cool that’s gonna make a lot of your favorite people really happy, and you have to keep it a secret?

News
January 14, 2024
2 min watch
Save

VIDEO: Fortisite allows for faster, cost saving treatment for corneal ulcers

VIDEO: Fortisite allows for faster, cost saving treatment for corneal ulcers

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye/Retina 2024, John A. Hovanesian, MD, FACS, discusses the benefits of treating corneal ulcers with Fortisite, a combination of tobramycin 1.5% and vancomycin 5%.

View more